Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000002676
http://purl.bioontology.org/ontology/NDFRT/N0000002676
|
|---|---|
| Preferred Name | Sarcoma, Kaposi [Disease/Finding] |
| Synonyms |
Sarcoma, Kaposi
Multiple Idiopathic Pigmented Hemangiosarcoma
Kaposi's Sarcoma
Kaposi Sarcoma
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
Sarcoma, Kaposi
Multiple Idiopathic Pigmented Hemangiosarcoma
Kaposi's Sarcoma
Kaposi Sarcoma
|
|---|---|
| prefLabel | Sarcoma, Kaposi [Disease/Finding]
|
| MESH DEFINITION | A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
|
| MESH DUI | D012514
|
| MESH UI | M0019437
|
| MeSH name | Sarcoma, Kaposi
|
| type | |
| tui | T191
|
| SNOMED CID | 109385007
|
| May be treated by |
See more
See less
|
| notation | N0000002676
|
| Semantic type UMLS property | |
| NUI | N0000002676
|
| cui | C0036220
|
| NDFRT kind | DISEASE_KIND
|
| Has contraindicated drug |
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |